The North America facial injectables market is quite monopolistic in nature with one player dominating the overall market dynamics. As of 2016, Allergan Plc., held a share 62.0% in the regional market. The company dominance is a result of the strong brand value of its drugs like Botox & Juvederm. Presently, Botox is leading the market and is expected to retain its stance all throughout 2024.
According to the research report, the North America facial injectables market is expected to reach a valuation of US$5.8 bn by the end of 2024 as compared to US$2.1 bn by the end of 2015. Between the forecast years of 2016 and 2024, the global market is expected to rise at a CAGR of 12.0%.
Browse Global Strategic Business Report:
North America Facial Injectables Market: Overview
The demand for facial injectables across North America has been on a continued rise due to changing lifestyles and rising disposable incomes. The increasing focus on physical appearance and aesthetics are also expected to drive the demand for facial injectables in the coming years. The research report states that the North America facial injectables market was valued at US$2.1 bn in 2015 and is expected to reach US$5.8 bn by the end of 2024. Between the forecast years of 2016 and 2024, the global market is expected to rise at a CAGR of 12.0%. The market for facial injectables in North America has also been gaining momentum due to the increased longevity of the effects of these injectables.
North America Facial Injectables Market: Segmentation
Based on product type, the North America facial injectables market has been segmented into Product Type – Botulinum Toxin; Hyaluronic Acid; Collagen: Porcine/ Bovine based & Human based; Particle & Polymer Fillers (PPF): Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid & Calcium Hydroxyapatite). The market has been further studied from the point of view of major treatment types. Based on treatment type, the market has been categorized into facial pain, wrinkle treatment, lip augmentation and others. Based on end users, the market has been segmented into hospitals, ambulatory surgical centers, cosmetic centers, dermatology clinics and physician clinics.
North America Facial Injectables Market: Regional Outlook
Geographically, the North America facial injectables market has been segmented into: the U.S. & Canada. The report also profiles major players in the facial injectables market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.
Key Players Mentioned in this Report are:
Key companies profiled in the report Allergan Plc., Galderma S.A. (Nestle), Merz Pharma & Co. KGaA, Prollenium Medical Technologies Inc., Ipsen Group and Bloomage BioTechnology Corporation Limited.
Download Exclusive Brochure of This Report :
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453